Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock

    NEXT STORY
    1,767 Orion Corporation A shares converted into B shares
    PREV STORY
    Kura Oncology Announces Commencement of Public Offering of Common Stock
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OSE Immunotherapeutics Receives €9.2 million Grant from Bpifrance “Invest in the Future Program” for Development of New Immune Checkpoint Inhibitor OSE-172 (Effi-DEM)

    NANTES, France, July 19, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE) announced ...

    author_avatar
    NASDAQ Market News

    Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist

    OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of ...

    author_avatar
    NASDAQ Market News

    BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer

    Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

    author_avatar
    NASDAQ Market News